Stay updated on IMAB362 in Combination With Nab-Paclitaxel and Gemcitabine Clinical Trial
Sign up to get notified when there's something new on the IMAB362 in Combination With Nab-Paclitaxel and Gemcitabine Clinical Trial page.

Latest updates to the IMAB362 in Combination With Nab-Paclitaxel and Gemcitabine Clinical Trial page
- Check2 days agoChange DetectedFooter now shows Revision: v3.3.4, replacing v3.3.3, reflecting the latest site revision.SummaryDifference0.0%

- Check9 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedA new history entry Revision: v3.3.3 was added, and the HHS Vulnerability Disclosure link along with the previous Revision: v3.3.2 entry were removed.SummaryDifference0.1%

- Check52 days agoChange DetectedThe page history shows a revision bump from v3.2.0 to v3.3.2, a metadata update with no visible changes to study content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check60 days agoChange DetectedDeletion removes an administrative notice about government funding and operating status, which does not affect trial data or the page's core purpose. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check74 days agoChange DetectedA new history entry (Version 77, 2025-10-17) was added, updating the Study Status. This reflects the latest status for the study in the record.SummaryDifference0.0%

- Check88 days agoChange Detected- Added a current date (2025-10-20) and a new study status entry (2025-10-17). - Removed an outdated date (2025-08-01).SummaryDifference0.7%

Stay in the know with updates to IMAB362 in Combination With Nab-Paclitaxel and Gemcitabine Clinical Trial
Enter your email address, and we'll notify you when there's something new on the IMAB362 in Combination With Nab-Paclitaxel and Gemcitabine Clinical Trial page.